Why is it so hard to implement change? A qualitative examination of barriers and facilitators to distribution of naloxone for overdose prevention in a safety net environment
Tóm tắt
The increase in opioid overdose deaths has become a national public health crisis. Naloxone is an important tool in opioid overdose prevention. Distribution of nasal naloxone has been found to be a feasible, and effective intervention in community settings and may have potential high applicability in the emergency department, which is often the initial point of care for persons at high risk of overdose. One safety net hospital introduced an innovative policy to offer take-home nasal naloxone via a standing order to ensure distribution to patients at risk for overdose. The aims of this study were to examine acceptance and uptake of the policy and assess facilitators and barriers to implementation. After obtaining pre-post data on naloxone distribution, we conducted a qualitative study. The PARiHS framework steered development of the qualitative guide. We used theoretical sampling in order to include the range of types of emergency department staff (50 total). The constant comparative method was initially used to code the transcripts and identify themes; the themes that emerged from the coding were then mapped back to the evidence, context and facilitation constructs of the PARiHS framework. Acceptance of the policy was good but uptake was low. Primary themes related to facilitators included: real-world driven intervention with philosophical, clinician and leadership support; basic education and training efforts; availability of resources; and ability to leave the ED with the naloxone kit in hand. Barriers fell into five general categories: protocol and policy; workflow and logistical; patient-related; staff roles and responsibilities; and education and training. The actual implementation of a new innovation in healthcare delivery is largely driven by factors beyond acceptance. Despite support and resources, implementation was challenging, with low uptake. While the potential of this innovation is unknown, understanding the experience is important to improve uptake in this setting and offer possible solutions for other facilities to address the opioid overdose crisis. Use of the PARiHS framework allowed us to recognize and understand key evidence, contextual and facilitation barriers to the successful implementation of the policy and to identify areas for improvement.
Tài liệu tham khảo
Chen LH, Hedegaard H, Warner M. QuickStats: rates of death from drug poisoning and drug poisoning involving opioid analgesics-United States, 1999–2013. MMWR. 2014;64(01):32.
Warner M, Hedegaard H, Chen LH. NCHS Health E Stat—trends in drug-poisoning deaths: United States, 1999–2012. 2014. http://www.cdc.gov/nchs/data/hestat/drug_poisoning/drug_poisoning.htm. Accessed 1 Dec 2015.
Centers for disease control and prevention, National Center on Health Statistics. NCHS data on drug poisoning deaths. 2015. http://www.cdc.gov/nchs/data/factsheets/factsheet_drug_poisoning.pdf. Accessed 1 Dec 2015.
Hedegaard H, Chen LH, Warner M. Drug-poisoning deaths involving heroin: United States, 2000–2013. Hyattsville, MD: National Center for Health Statistics; 2015. http://www.cdc.gov/nchs/data/databriefs/db190.htm. Accessed 1 Dec 2015.
Massachusetts Department of Public Health. Data brief: fatal opioid-related overdoses among Massachusetts residents. 2015. http://www.mass.gov/eohhs/docs/dph/quality/drugcontrol/county-level-pmp/data-brief-jul-2015-overdose-county.pdf. Accessed 1 Dec 2015.
Massachusetts Governor’s Opioid Working Group. Recommendations of the governor’s Opioid Working Group. Massachusetts; 2015:47. https://s3.amazonaws.com/s3.documentcloud.org/documents/2108551/recommendations-of-baker-panel-on-mass-opioid.pdf. Accessed 1 Dec 2015.
Wheeler E, Jones S, Gilbert M, Davidson P. Opioid overdose prevention programs providing naloxone to laypersons-United States, 2014. Morb Mortal Wkly Rep. 2015;64(23):631–5.
Doe-Simkins M, Walley AY, Epstein A, Moyer P. Saved by the nose: Bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health. 2009;99(5):788–91. doi:10.2105/AJPH.2008.146647.
Walley AY, Doe-Simkins M, Quinn E, Pierce C, Xuan Z, Ozonoff A. Opioid overdose prevention with intranasal naloxone among people who take methadone. J Subst Abuse Treat. 2013;44(2):241–7. doi:10.1016/j.jsat.2012.07.004.
Davis CS, Walley AY, Bridger CM. Lessons learned from the expansion of naloxone access in Massachusetts and North Carolina. J Law, Med Ethics. 2015;43(s1):19–22.
Davis CS, Carr D. Legal changes to increase access to naloxone for opioid overdose reversal in the United States. Drug Alcohol Depend. 2015;1(157):112–20.
Green TC, Dauria EF, Bratberg J, Davis CS, Walley AY. Orienting patients to greater opioid safety: models of community pharmacy-based naloxone. Harm Reduct J. 2015;12(1):1.
Payne TH, Hoey PJ, Nichol P, Lovis C. Preparation and use of preconstructed orders, order sets, and order menus in a computerized provider order entry system. J Am Med Inform Assoc. 2003;10:322–9.
Ozdas A, Speroff T, Waitman RL, Ozbolt J, Butler J, Miller RA. Integrating “best of care” protocols into clinicians’ workflow via care provider order entry: impact on quality-of-care indicators for acute myocardial infarction. J Am Med Inform Assoc. 2006;13:188–96.
Micek ST, Roubinian N, Heuring T, et al. Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med. 2006;34(11):2707–13.
Lee F, Teuch JM, Spurr CD, Bates CW. Implementation of a physician order entry system: user satisfaction and self reported usage patterns. J Am Med Inform Assoc. 1996;3(1):42–55.
Samuels EA, Dwyer K, Mello MJ, Baird J, Kellogg AR, Bernstein E. Emergency department-based opioid harm reduction: moving physicians from willing to doing. Acad Emerg Med. 2016;23:455–65.
Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The DAWN report: highlights of the 2011 drug abuse warning network (DAWN) findings on drug-related emergency department visits, Rockville. 2013. http://www.samhsa.gov/data/sites/default/files/DAWN127/DAWN127/sr127-DAWN-highlights.pdf. Accessed 5 Dec 2015.
Center for behavioral health statistics and quality. Guide to DAWN trend tables, 2011 update. Rockville: substance abuse and mental health services administration. 2013. http://www.samhsa.gov/data/sites/default/files/Nation_2011_Illicit.xls. Accessed 7 Dec 2015.
American public health association. Policy no. LB-11-03. Preventing overdose through education and naloxone distribution. 2012. http://www.apha.org/advocacy/policy/policysearch/default.htm?id=1429. Accessed 1 Dec 2015.
The executive office of the president of the United States. Epidemic: Responding to America’s prescription drug abuse crisis. 2011. http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/rx_abuse_plan.pdf. Accessed 1 Dec 2015.
Dwyer K, Walley AY, Langlois BK, Mitchell P, Nelson KP, Cromwell J, Bernstein E. Opioid education and nasal naloxone rescue kits in the emergency department. West J Emerg Med. 2015;16(3):381–4.
Rycroft-Malone J. The PARIHS framework—a framework for guiding the implementation of evidence-based practice. J Nurs Care Qual. 2004;19(4):297–304.
Pope C, Ziebland S, Mays N. Analysing qualitative data. BMJ. 2000;320(7227):114–6.
Glaser BG, Strauss AL. The discovery of grounded theory: strategies for qualitative research. Chicago: Aldine Publishing Company; 1967. p. 1967.
Kitson AL, Rycroft-Malone J, Harvey G, McCormack B, Seers K, Titchen A. Evaluating the successful implementation of evidence into practice using the PARIHS framework: theoretical and practical challenges. Implementation Science. 2008;3:1.
Beletsky L, Ruthazer R, Macalino GE, Rich JD, Tan L, Burris S. Physicians’ knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities. J Urban Health. 2007;84(1):126–36.
Leece P, Orkin A, Shahin R, Steele LS. Can naloxone prescription and overdose training for opioid users work in family practice? Perspectives of family physicians. Can Fam Physician. 2015;61(6):538–43.
Green TC, Bowman SE, Zaller ND, Ray M, Case P, Heimer R. Barriers to medical provider support for prescription naloxone as overdose antidote for lay responders. Subst Use Misuse. 2013;48(7):558–67.
Paulozzi LJ. Prescription drug overdoses: a review. J Saf Res. 2012;43(4):283–9. doi:10.1016/j.jsr.2012.08.009.
Lake SE, Hayashi K, Buxton J, Milloy M-J, Dong H, Wood E, Montaner J, Kerr T. The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs. Drug Alcohol Depend. 2015;156:297–303.
D’Onofrio G, O’Connor PG, Pantalon MV, Chawarski MC, Busch SH, Owens PH, Bernstein SL, Fiellin DA. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313(16):1636–44.
Yevchak AM, Fick DM, McDowell J, Monroe T, May K, Grove L, Kolanowski AM, Waller JL, Inouye SK. Barriers and facilitators to implementing a delirium rounds in a clinical trial across three diverse hospital settings. Clin Nurs Res. 2014;23(2):201–15.
Chaudoir SR, Dugan AG, Barr CH. Measuring factors affecting implementation of health innovations: a systematic review of structural, organizational, provider, patient, and innovation level measures. Implement Sci. 2013;8:22.
Matheson C, Pflanz-Sinclair C, Aucott L, Wilson P, Watson R, Malloy S, Dickie E, McAuley A. Reducing drug related deaths: a pre-implementation assessment of knowledge, barriers and enablers for naloxone distribution through general practice. BMC Fam Pract. 2014;15:12.
Leggat SG, Balding C. Achieving organizational competence for clinical leadership. J Health Organ Manag. 2013;27(3):312–29. doi:10.1108/JHOM-Jul-2012-0132.
Weaver SJ, Dy SM, Rosen MJ. Narrative review: team-training in healthcare: a narrative synthesis of the literature. BMJ Qual Saf. 2014;23(5):359–72. doi:10.1136/bmjqs-2013-001848.
Van Bogaert P, Clarke S, Willems R, Mondelaers M. Staff engagement as a target for managing work environments in psychiatric hospitals: implications for workforce stability and quality of care. J Clin Nurs. 2013;22(11–12):1717–28.
D’Onofrio G, Fiellin DA, Pantalon MV, Chawarski MC, Owens PH, Degutis LC, Busch SH, Bernstein SL, O’connor PG. A brief intervention reduces hazardous and harmful drinking in emergency department patients. Ann Emerg Med. 2012;60(2):181–92.
Stanley B, Brown GK, Currier GW, Lyons C, Chesin M. Brief intervention and follow-up for suicidal patients with repeat emergency department visits enhances treatment engagement. Am J Public Health. 2015;105(8):1570–2.
Birken SA, Lee S-YD, Weiner BJ. Uncovering middle managers’ role in healthcare innovation implementation. Implementation Science. 2012;7:28.
Ellison J, Walley AY, Feldman JA, Bernstein E, Mitchell P, Koppelman EA, Drainoni ML. Identifying patients for overdose prevention with ICD-9 classification in the emergency department, Massachusetts, 2013–2014. Public Health Rep Sept. 2016;131:671–5.